Teriparatide 560MCG/2.24ML pen 2.24ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM4T8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,083
Award facts
- Contract value 100% obligated
- $14,083.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Teriparatide 560mcg/2.24ml pen injections, with a ceiling value of $14,083.38 and an ultimate completion date of November 25, 2025. This is a non-set-aside contract executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The delivery order will be fulfilled at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania.
Teriparatide is a bone-building medication commonly prescribed for osteoporosis treatment, particularly for patients at high risk of fractures. As a major pharmaceutical distributor and critical vendor in the federal medical supply chain, AmerisourceBergen serves military and veteran healthcare systems, the Defense Health Agency, and other government entities through its extensive portfolio of brand-name and generic medications. This delivery order represents a routine pharmaceutical procurement supporting military healthcare operations under the established global pharmaceutical prime vendor vehicle, demonstrating the company's continued capability to meet federal medical supply requirements through competitive procurement processes.
Quick answers
Who was awarded contract SPE2DR26FM4T8?
SPE2DR26FM4T8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FM4T8 worth?
The government has obligated $14,083 on SPE2DR26FM4T8.
Is contract SPE2DR26FM4T8 an order under another contract?
Yes. SPE2DR26FM4T8 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM4T8 competed?
The extent of competition for SPE2DR26FM4T8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award